| Louis Ricciardiello, DMD | |
|
96 High St, Laconia, NH 03246-3537 | |
| (603) 527-1700 | |
| (603) 527-1785 |
| Full Name | Louis Ricciardiello |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 96 High St, Laconia, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396863379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Louis Ricciardiello, DMD 96 High St, Laconia, NH 03246-3537 Ph: (603) 527-1700 | Louis Ricciardiello, DMD 96 High St, Laconia, NH 03246-3537 Ph: (603) 527-1700 |
News Archive
As President Donald Trump talked tax reform on Capitol Hill Tuesday, Arkansas patient advocate Andrea Taylor was also meeting with lawmakers and asking them to save a corporate tax credit for rare disease drug companies.
Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body.
Optimal methods for predicting treatment efficacy in patients with esophageal cancer are seriously lacking. But now, researchers from Japan have found a useful alternative to existing methods for predicting patient outcomes.
Ben-Gurion University of the Negev and University of Western Australia researchers have developed a new process to develop few-layer graphene for use in energy storage and other material applications that is faster, potentially scalable and surmounts some of the current graphene production limitations.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
› Verified 1 days ago
Dr. Robert Andrew Mooney, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 237 Court St, Laconia, NH 03246 Phone: 603-524-4400 | |
Dr. Raymond Thomas Finn Jr., DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 376 Union Ave, Laconia, NH 03246 Phone: 603-524-1085 | |
Dr. David S Ieni, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 483 Union Ave, Laconia, NH 03246 Phone: 603-528-4444 | |
Dr. Jeffrey R. Crowell, DMD Dentist Medicare: Medicare Enrolled Practice Location: 483 Union Ave, Laconia, NH 03246 Phone: 603-528-4444 | |
Dr. Alan F Kennell, DDS, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 783 N Main St, Laconia, NH 03246 Phone: 603-524-7404 Fax: 603-524-7405 | |
Dr. William Darren Boles, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 36 Endicott St East, Laconia, NH 03246 Phone: 603-366-4400 Fax: 603-366-4410 | |
Dr. Everett R Johnson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 734 N Main St, Laconia, NH 03246 Phone: 603-524-8159 Fax: 603-524-4506 |